Mineralys Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
– Commenced patient dosing in lorundrostat pivotal clinical program, for the treatment of patients with…
– Commenced patient dosing in lorundrostat pivotal clinical program, for the treatment of patients with…
– Commenced patient dosing in lorundrostat pivotal clinical program, for the treatment of patients with…
– 1Q23 total revenue of $6.2M including collaborative revenue of $2.8M from the Company’s share…
– 1Q23 total revenue of $6.2M including collaborative revenue of $2.8M from the Company’s share…
Company has initiated pre-IND discussions with the FDA for its first AIM INJ indication NEXI-001…
Company has initiated pre-IND discussions with the FDA for its first AIM INJ indication NEXI-001…
PHOENIX, May 15, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the…
PHOENIX, May 15, 2023 (GLOBE NEWSWIRE) — MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the…
REDWOOD CITY, Calif., May 15, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS),…
NEWS RELEASE – REGULATED INFORMATION15 MAY 2023, 4:00PM EDT / 22:00 CET MDxHealth…
Calls on Stockholders to Vote on your BLUE Proxy Card DALLAS–(BUSINESS WIRE)–First Foundation Inc. (NASDAQ:…
Gross margin of $5.41 million (62%) for the first quarter of Fiscal 2023 as compared…
High Growth Continues with Revenue up 38% and ARR up 29% Vancouver, British Columbia–(Newsfile Corp….
Total MRI scan volume at the HMCA-managed sites increased 7% to 49,451 scans for the…
PASADENA, Calif.–(BUSINESS WIRE)–Dine Brands Global, Inc. (NYSE: DIN), the parent company of Applebee’s Neighborhood Grill…
Conference Call and Webcast May 16 at 8:00 am Eastern Time / 7:00 am Central…
Improved operating results driven by lower SG&A expense and expanded gross margin ELYRIA, Ohio–(BUSINESS WIRE)–Invacare…
Q1 2023 revenue of $15.5 million, up 10% year-over-year and slightly above the guidance range…
Regulated Information Leuven, Belgium, Boston, MA, US – May 15, 2023 – 08.00 PM CET – Oxurion NV (Euronext…
Regulated Information Leuven, Belgium, Boston, MA, US – May 15, 2023 – 08.00 PM CET – Oxurion NV (Euronext…